DMBT1 and inflammatory bowel disease: Patients with IBD and the TT genotype of DMBT1 rs2981745 had fewer events of severe relapses per 1 year of disease than the carriers of the rest of the genotypes (CC: 0.2 (0.0–0.5) vs. CT: 0.1 (0.0–0.5) vs. TT: 0.0 (0.0–0.3); p = 0.035) (Supplementary Table S8).